Alexza Pharmaceuticals Inc. (ALXA) SVP, CFO & Sec August J Moretti sells 10,000 Shares

SVP, CFO & Sec of Alexza Pharmaceuticals Inc. (ALXA, Financial) August J Moretti sells 10,000 shares of ALXA on 05/05/2010 at an average price of $3.5 a share.

Alexza Pharmaceuticals Inc. has a market cap of $172.9 million; its shares were traded at around $3.29 with and P/S ratio of 18.1.

ALXA is in the portfolios of Jim Simons of Renaissance Technologies LLC.

CEO Recent Trades:

  • Sell:: Pres & CEO Thomas Braxton King sold 44,994 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.

  • Sell:: Pres & CEO Thomas Braxton King sold 45,000 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.



CFO Recent Trades:

  • Sell:: SVP, CFO & Sec August J Moretti sold 14,009 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.

  • Sell:: SVP, CFO & Sec August J Moretti sold 14,000 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.



Directors and Officers Recent Trades:

  • Sell:: SVP, Research & Development James V Cassella sold 24,424 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.

  • Sell:: SVP, Operations & Quality Michael J Simms sold 9,770 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.

  • Sell:: SVP, Research & Development James V Cassella sold 24,419 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.

  • Sell:: SVP, Operations & Quality Michael J Simms sold 9,767 shares of ALXA stock on 12/18/2009 at the average price of 2.23, the price of the stock has increased by 47.53% since.